| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/14/2011 | US7960115 DNA binding protein |
| 06/14/2011 | US7960107 Method of determining the susceptibility of a subject to developing insulin-dependent diabetes |
| 06/14/2011 | US7959933 Activatable recombinant neurotoxins |
| 06/14/2011 | US7959929 isolated influenza virus that is capable of infecting a canid animal; genetic engineered influenza virus; vaccines for inducing an immune response against an influenza virus; veterinary medicine |
| 06/14/2011 | US7959918 Methods for treating vascular disease |
| 06/14/2011 | US7959910 C-terminally truncated interferon alpha variants |
| 06/14/2011 | US7959909 Cysteine variants of interferon gamma |
| 06/14/2011 | US7959908 Methods of treating viral infections using IL-21 |
| 06/14/2011 | US7959659 Bioabsorbable stents; vascular disorders, occlusion treatment such as restenosis or vulnerable plaque; atherosclerosis, diabetes; anticoagulants |
| 06/14/2011 | CA2602145C Extracting biopolymers from a biomass using ionic liquids |
| 06/14/2011 | CA2600177C Human skin equivalents expressing exogenous polypeptides |
| 06/14/2011 | CA2494241C Botulinum toxin pharmaceutical compositions |
| 06/14/2011 | CA2476177C Purification of red blood cells by separation and diafiltration |
| 06/14/2011 | CA2475534C Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 06/14/2011 | CA2413546C Modification of hepatitis b core antigen |
| 06/14/2011 | CA2405084C Neutralizing immunogenic hev polypeptides |
| 06/14/2011 | CA2399846C Gm-negative ehv-mutants |
| 06/14/2011 | CA2359705C Chromatographic process for purification of albumin |
| 06/14/2011 | CA2322700C Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to binds to preselected sites |
| 06/14/2011 | CA2311646C Tsa305 gene |
| 06/14/2011 | CA2297786C New immunoprotective influenza antigen and its use in vaccination |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/14/2011 | CA2210732C Recombinant swinepox virus |
| 06/14/2011 | CA2182621C Galanin receptor, nucleic acids, transformed cells and uses thereof |
| 06/14/2011 | CA2178212C Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 06/09/2011 | WO2011068953A2 Atoxic recombinant holotoxins of clostridium difficile as immunogens |
| 06/09/2011 | WO2011068893A1 BINDING PROTEINS THAT BIND TO HUMAN FGFR1C, HUMAN β-KLOTHO AND BOTH HUMAN FGFR1C AND HUMANβ-KLOTHO |
| 06/09/2011 | WO2011068853A2 TREATMENT OF IgE-MEDIATED DISEASE |
| 06/09/2011 | WO2011068792A2 Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells |
| 06/09/2011 | WO2011068261A1 Gene which enhances resistance to plant pathogens and use thereof |
| 06/09/2011 | WO2011068176A1 Method for detecting cholangiocellular carcinoma and method of screening for prophylactic or therapeutic agent |
| 06/09/2011 | WO2011068019A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein |
| 06/09/2011 | WO2011067971A1 Human sweet taste receptor agonist sweetness regulating substance for sweet substances |
| 06/09/2011 | WO2011067283A1 Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases |
| 06/09/2011 | WO2011067175A1 Ofa/ilrp derived modified peptide |
| 06/09/2011 | WO2011066995A1 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins |
| 06/09/2011 | WO2011066711A1 Specific antigen of clonorchis sinensis and uses thereof |
| 06/09/2011 | WO2011045454A3 Multifunctional nanostructures as spect/mri bimodal diagnosis agents |
| 06/09/2011 | WO2011041256A3 Insecticidal proteins |
| 06/09/2011 | WO2011024072A3 Hybrid polypeptides including meningococcal fhbp sequences |
| 06/09/2011 | WO2011020119A3 Methods of treating cancer using glucagon-like hormone retargeted endopeptidases |
| 06/09/2011 | WO2011007133A3 Polymer modified macromolecules |
| 06/09/2011 | WO2011005341A3 Compositions and methods related to protein a (spa) variants |
| 06/09/2011 | WO2010058100A8 Mutant proteins of the f protein of piv-5 and piv-2 |
| 06/09/2011 | WO2009126808A3 Transgenic animal model of cancer and methods of use |
| 06/09/2011 | WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 06/09/2011 | US20110138496 Polypeptide for improving tolerance to iron deficiency in plants, and use thereof |
| 06/09/2011 | US20110138495 Methods and Compositions for Expressing Proteins In Plants |
| 06/09/2011 | US20110137013 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 06/09/2011 | US20110137012 Cell culture method using amino acid-enriched medium |
| 06/09/2011 | US20110137011 Hyperglycosylated human coagulation factor ix |
| 06/09/2011 | US20110136896 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| 06/09/2011 | US20110136895 Methods and compositions for modulating PD1 |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136745 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136740 CYSTINE KNOT PEPTIDES BINDING TO ALPHA IIb BETA 3 INTEGRINS AND METHODS OF USE |
| 06/09/2011 | US20110136737 DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties |
| 06/09/2011 | US20110136736 New insulin analogues of prolonged activity |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136723 Novel reagents and method for conjugating biological molecules |
| 06/09/2011 | US20110136682 Antennary fucosylation in glycoproteins from cho cells |
| 06/09/2011 | US20110136260 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching |
| 06/09/2011 | US20110136229 Novel lectin |
| 06/09/2011 | US20110136224 Mda-7 proteins and methods of use thereof |
| 06/09/2011 | US20110136223 Neurturin receptor |
| 06/09/2011 | US20110136209 Process for the preparation of nicotine-based haptens |
| 06/09/2011 | US20110136175 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 06/09/2011 | US20110136172 Mammalian cytokines; related reagents |
| 06/09/2011 | US20110136155 Peptides and methods for the detection of lyme disease antibodies |
| 06/09/2011 | US20110136147 Methods of identifying tumor associated glycoproteins |
| 06/09/2011 | US20110136137 Serum proteomic for finding diagnostic markers and for monitoring therapeutical intervention in treatment of hepatocellular carcinoma |
| 06/09/2011 | US20110136121 Method for detecting cancer |
| 06/09/2011 | US20110136113 Marker for detecting il-17-producing helper t cell, and method for detecting il-17-producing helper t cell |
| 06/09/2011 | US20110136108 XBP1(S) Protein Acting as an Adipocyte Differentiation Marker Having a Facility to Regulate Differentiation into Adipocytes, and an Application Therefor |
| 06/09/2011 | US20110135736 Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent |
| 06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
| 06/09/2011 | US20110135689 Vaccine, therapeutic composition and methods for treating or inhibiting francisella tularenis |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135682 Recombinant Bicistronic Flaviviruses and Methods of Use Thereof |
| 06/09/2011 | US20110135680 Deletion mutants of flagellin and methods of use |
| 06/09/2011 | US20110135677 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135672 Hla-g compositions and methods of use thereof |
| 06/09/2011 | US20110135659 Fish Vaccine |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135649 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135640 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135619 Polypeptides of Alicyclobacillus sp. |
| 06/09/2011 | US20110135614 Modified growth hormone |
| 06/09/2011 | US20110135606 Test systems for the analysis of polypeptides and cells adhering to silicones |
| 06/09/2011 | US20110135602 Supperssor of the endogenous interferon-gamma |